Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 40.58%82.28B | 163.43%161.42B | -1.86%116.2B | 7.43%375.95B | 69.05%137.75B | 9.63%58.53B | -34.38%61.28B | -2.70%118.39B | 2.78%349.94B | -30.53%81.49B |
Cost of revenue | 41.06%60.59B | 166.75%116.64B | 5.54%84.38B | 7.40%266.83B | 61.76%100.21B | 10.66%42.95B | -28.67%43.73B | -7.46%79.95B | 0.21%248.45B | -31.67%61.95B |
Gross profit | 39.25%21.69B | 155.16%44.78B | -17.24%31.82B | 7.52%109.12B | 92.13%37.54B | 6.87%15.58B | -45.29%17.55B | 8.93%38.45B | 9.67%101.49B | -26.68%19.54B |
Operating expense | 32.06%11.29B | 44.64%12.71B | 13.39%12.65B | 4.32%38.61B | 0.01%10.11B | 10.29%8.55B | -6.05%8.79B | 13.95%11.16B | 9.63%37.01B | 6.45%10.11B |
Operating profit | 47.99%10.4B | 266.04%32.07B | -29.76%19.17B | 9.35%70.51B | 190.91%27.43B | 2.99%7.03B | -61.44%8.76B | 7.00%27.29B | 9.69%64.48B | -45.03%9.43B |
Net non-operating interest income (expenses) | -20.25%-2.55B | -29.84%-2.51B | -14.44%-2.25B | -16.77%-8.09B | -19.17%-2.07B | -24.74%-2.12B | -15.92%-1.93B | -7.84%-1.97B | 14.48%-6.93B | 25.35%-1.74B |
Non-operating interest income | 219.15%150M | 118.52%118M | 618.18%79M | 796.43%251M | 1,637.50%139M | 683.33%47M | 800.00%54M | 37.50%11M | 33.33%28M | -27.27%8M |
Non-operating interest expense | 33.48%2.45B | 31.61%2.32B | 24.05%2.09B | 19.17%7.26B | 29.79%1.98B | 22.47%1.84B | 19.82%1.76B | 5.37%1.69B | -8.59%6.09B | -8.19%1.52B |
Total other finance cost | -24.62%251M | 37.33%309M | -18.62%236M | 25.17%1.08B | 4.52%231M | 60.10%333M | 10.84%225M | 26.09%290M | -40.76%862M | -67.40%221M |
Net investment income | -215.31%-1.39B | -293.71%-1.57B | 102.05%2.46B | -8.73%3.22B | -102.37%-11M | -16.53%1.2B | 36.07%811M | 18.50%1.22B | -32.96%3.53B | -80.64%464M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | -63M | 1,983.72%810M | -3M | 2.72B | 45,950.00%2.76B | 0 | -43M | 0 | 0 | -99.82%6M |
Income from associates and other participating interests | -142.57%-633M | -24.86%816M | -98.47%13M | 114.79%3.92B | 140.98%500M | 1,831.17%1.49B | -64.76%1.09B | 842.98%847M | 116.89%1.83B | 88.82%-1.22B |
Special income (charges) | 40,300.00%804M | -119.73%-29M | -5,166.67%-1.26B | -384.36%-3.78B | -332.26%-3.9B | 98.56%-2M | -6.96%147M | -123.30%-24M | -160.05%-780M | -188.18%-902M |
Less:Restructuring and mergern&acquisition | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---882M | ---- |
Less:Other special charges | 440.00%17M | 122.98%37M | -5,157.14%-1.06B | 201.75%3.62B | 149.73%3.77B | -150.00%-5M | 5.85%-161M | 115.56%21M | 176.34%1.2B | 2,150.75%1.51B |
Less:Write off | -11,828.57%-821M | -157.14%-8M | 77,433.33%2.33B | -66.02%157M | -51.81%133M | -95.04%7M | 7.69%14M | -90.63%3M | 69.23%462M | 12.20%276M |
Other non-operating income (expenses) | -1,803.45%-552M | -320.93%-95M | -61.63%33M | -113.38%-84M | -142.11%-184M | 81.05%-29M | -85.37%43M | -84.72%86M | -44.52%628M | -109.37%-76M |
Income before tax | -20.50%6.02B | 232.47%29.5B | -33.87%18.15B | 9.02%68.41B | 311.15%24.53B | 20.29%7.57B | -64.77%8.87B | 8.45%27.45B | 11.59%62.75B | -41.60%5.97B |
Income tax | -20.59%1.69B | 249.98%9.29B | -34.24%6.22B | 20.90%22.57B | 320.16%8.34B | 6.79%2.12B | -61.34%2.66B | 20.80%9.46B | -8.03%18.67B | -68.99%1.98B |
Net income | -20.44%4.33B | 224.98%20.2B | -33.67%11.93B | 3.99%45.84B | 306.55%16.19B | 26.55%5.44B | -66.06%6.22B | 2.92%17.99B | 22.67%44.08B | 4.32%3.98B |
Net income continuous operations | -20.46%4.33B | 225.00%20.21B | -33.67%11.93B | 3.99%45.84B | 306.66%16.19B | 26.52%5.44B | -66.06%6.22B | 2.92%17.99B | 22.66%44.08B | 4.30%3.98B |
Noncontrolling interests | 169.71%472M | 11.54%174M | 14.77%272M | -25.76%758M | -38.71%190M | -27.39%175M | -27.10%156M | -7.42%237M | 5.04%1.02B | 4.73%310M |
Net income attributable to the company | -26.76%3.86B | 230.49%20.03B | -34.32%11.66B | 4.70%45.08B | 335.82%16B | 29.75%5.27B | -66.52%6.06B | 3.07%17.76B | 23.16%43.06B | 4.29%3.67B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -26.76%3.86B | 230.49%20.03B | -34.32%11.66B | 4.70%45.08B | 335.82%16B | 29.75%5.27B | -66.52%6.06B | 3.07%17.76B | 23.16%43.06B | 4.29%3.67B |
Gross dividend payment | ||||||||||
Basic earnings per share | -26.65%18.5 | 230.61%95.91 | -34.33%55.82 | 4.69%215.82 | 335.67%76.59 | 29.73%25.22 | -66.52%29.01 | 3.07%85 | 23.18%206.15 | 4.27%17.58 |
Diluted earnings per share | -26.71%18.4839 | 230.61%95.91 | -34.33%55.82 | 4.69%215.82 | 335.80%76.5857 | 29.73%25.22 | -66.52%29.01 | 3.07%85 | 23.18%206.15 | 4.29%17.5737 |
Dividend per share | 0 | 2.78%37 | 0 | 12.31%73 | 2.78%37 | 0 | 24.14%36 | 0 | 27.45%65 | 33.33%36 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |